Galena Biopharma to Present at the Rodman & Renshaw 14th Annual Investment Conference

LAKE OSWEGO, Ore., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will present a corporate overview at the Rodman and Renshaw 14th Annual Healthcare Conference. The presentation will take place on Monday, September 10, 2012 at 2:50 p.m. EDT at the Waldorf Astoria Hotel in New York, NY.